Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2620 of 5804
-
Custom eye exercises show promise for stubborn lazy eye in kids
Symptom relief CompletedThe primary objective of this study is to evaluate the effects of a personalized vision therapy programme tailored to baseline visual-cognitive abilities in treatment-resistant amblyopia. In addition to testing the hypothesis that rehabilitation protocols targeting amblyopia rela…
Sponsor: Okan University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New drug MDX2001 tested in 285 patients with advanced cancers
Disease control Recruiting nowThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug targets cancer DNA in advanced tumors
Disease control Recruiting nowThis phase I trial studies how well CBX-12 works in treating patients with solid tumors that have spread from where they first started (primary site) to started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or other places in the body (metastatic). CBX-12…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Honest placebos: a new way to fight the opioid crisis?
Symptom relief Recruiting nowThis study aims to evaluate whether the reduction of the daily morphine equivalent dose (MED) in patients with subacute and chronic pain can be decreased with an open-label placebo (OLP) intervention in comparison to an electronic monitoring (EM) control group. The participants w…
Phase: NA • Sponsor: Cosima Locher • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
One online class could ease chronic pain – spanish version tested
Symptom relief Recruiting nowEmpowered Relief (ER) is a 1-session pain relief skills intervention that is delivered in-person or online by certified clinicians to groups of patients with acute or chronic pain. Prior work in has shown ER efficacy for reducing chronic pain, pain-related distress, and other sym…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a common diabetes pill boost Teplizumab's effects in early type 1 diabetes?
Disease control Recruiting nowThe goal of this study is to determine how a drug class called glucagon-like peptide-1 receptor agonists (GLP-1Ra) affects people during an early stage of Type 1 Diabetes undergoing clinical teplizumab treatment. This study involves giving participants a liquid meal under differe…
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New scan may predict dangerous clot return in lung patients
Knowledge-focused Recruiting nowMajor risk after pulmonary embolism (PE) is recurrence, fatal in 10% of patients. Patients with PE can be stratified in 3 groups according to the risk of recurrence : very low risk, high risk or Intermediate risk. Little is known about this last group. Anticoagulation is efficie…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a phone app help tame diabetes? new study investigates
Disease control OngoingThis clinical study aims to evaluate the effects of using the "WellCheck" mobile application on blood glucose, blood pressure, and weight among Type 2 diabetes patients in real primary care settings. It is a prospective, multi-center, cluster-randomized, pragmatic clinical trial.…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 26, 2026 12:36 UTC
-
New program aims to get stroke survivors moving again
Symptom relief Recruiting nowThe goal of this study is to learn if a behavioral change intervention can improve physical activity in stroke survivors living in the community. The main question it aims to answer is, if a behaviour change intervention and personalised physical activity prescription, are effec…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Brain patch trial aims to sharpen thinking in schizophrenia
Symptom relief Recruiting nowThis is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers and measures of cognition. Additional goals are to assess pharmacokinetic (PK), s…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Morning or evening workout: which lowers blood pressure best?
Symptom relief Recruiting nowThe treatment of high blood pressure, or hypertension, is multifaceted and can include pharmacological therapies (i.e., medications) and lifestyle modifications such as physical activity. Chronotherapy, which describes timing of a treatment with the body's daily rhythms, has rece…
Phase: NA • Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy shows promise for resistant depression
Symptom relief TerminatedThis is a randomized clinical trial to test the effectiveness of combining a proven psychological intervention called behavioural activation therapy alongside esketamine treatment for treatment resistant major depressive episodes in individuals with major depressive disorder or b…
Phase: NA • Sponsor: The Royal's Institute of Mental Health Research • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a common sedative keep agitated lung patients off ventilators?
Symptom relief CompletedMany studies approved dexmedetomodine as a drug controlled agitation for psychotic patients and also for patients on non invasive ventilation. So we study the same effect on agitated patients who are on non invasive ventilation and also suffer of psychosis as agitation become mo…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Mesh may keep hernias away after reflux surgery
Disease control Recruiting nowThe aim of this study is to find out if using a certain kind of mesh can reduce the chances of hiatal hernias coming back after anti-reflux surgery. Participants undergoing antireflux surgery will be assigned to one of two groups, a group that has surgery with mesh, or a group th…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can free produce and coaching lower blood pressure? new study tests a fresh approach
Disease control CompletedTHRIVE intervention is a 2-arm randomized pilot trial testing the feasibility and preliminary efficacy of producing prescriptions, tailored dietitian counseling with adaptive messages, and linkages to social resources among 80 Black adults with hypertension.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New device aims to filter toxins in liver crisis
Disease control Recruiting nowA Prospective, Single-Center trial, in Patients With Acute on Chronic Liver Failure. Study of Standard Medical Care Plus CytoSorb® Compared to Standard Medical Care Alone in a historical group.
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo may help women with PCOS ovulate when standard treatment fails
Disease control CompletedClomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickn…
Phase: PHASE1 • Sponsor: HITEC-Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of peposertib (M3814) in combination with tuvusertib (M1774) in treating patients with solid tumors that have spread to other places in the body (advanced). Peposertib and tuvusertib stop the growth of tumor cells by…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Migraine drug shows promise for IBS belly pain in small study
Symptom relief CompletedThe primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Nighttime drug may boost recovery after surgery in seniors
Symptom relief Recruiting nowIn the aftermath of major surgery, many patients suffer from pain, fatigue, reduced general well-being, and cognitive dysfunction. Another common concern after major surgery is sleep impairment and there is little known about its effect on postoperative morbidity, especially post…
Phase: PHASE4 • Sponsor: Ziekenhuis Oost-Limburg • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC